Clinicohistologic diagnoses and results of adherence assays, autologous and allogeneic transplant recipients*
| Patients . | HLA match . | Posttransplantation day at biopsy . | Clinicohistologic diagnosis . | Adherence . |
|---|---|---|---|---|
| 410, 495, 258, 473 (n = 4) | Autologous | 5, 8, 34, 40 | Morbilliform eruption | No |
| 541, 354, 368, 373, 380 (n = 5) | Autologous | 8, 15, 40, 49, 52 | G-CSF reaction | No |
| 416, 414, 581, 448, 269, 584, 382 (n = 7) | Autologous | 4, 15, 20, 24, 26, 32, 36 | Interface dermatitis (erythema multiformae [EM]/drug eruption) | No |
| 359 | Autologous | 4 | No pathologic change | No |
| 271, 272 (n = 2) | Autologous | 12, 41 | Spongiotic dermatitis | No |
| 358 | Autologous | 1 | Pityrosporumfolliculitis | No |
| 55 | 6/6 | 101 | Phototoxic eruption | No |
| 79 | 6/6 | 18 | Morbilliform eruption | No |
| 85 | 6/6 | 41 | Spongiotic dermatitis | No |
| 103 | 6/6 | 31 | Morbilliform eruption | No |
| 119 | 6/6 | 33 | Morbilliform eruption | No |
| 132 | 6/6 | 21 | Interface dermatitis (EM/drug eruption) | No |
| 303, 352 (n = 2) | Autologous | 5, 21 | Morbilliform eruption | Yes |
| 92 | 6/6 | 73 | Grade II GVHD | Yes |
| 99 | 6/6 | 34 | Grade II GVHD | Yes |
| 116 | 6/6 | 34 | Grade II GVHD | Yes |
| 121 | 6/6 | 26 | Grade II GVHD | Yes |
| 137 | 6/6 | 21 | Grade II GVHD | Yes |
| 139 | 5/6 | 13 | Grade I GVHD | Yes |
| 81 | 5/6 | 25 | Grade II GVHD | Yes |
| Patients . | HLA match . | Posttransplantation day at biopsy . | Clinicohistologic diagnosis . | Adherence . |
|---|---|---|---|---|
| 410, 495, 258, 473 (n = 4) | Autologous | 5, 8, 34, 40 | Morbilliform eruption | No |
| 541, 354, 368, 373, 380 (n = 5) | Autologous | 8, 15, 40, 49, 52 | G-CSF reaction | No |
| 416, 414, 581, 448, 269, 584, 382 (n = 7) | Autologous | 4, 15, 20, 24, 26, 32, 36 | Interface dermatitis (erythema multiformae [EM]/drug eruption) | No |
| 359 | Autologous | 4 | No pathologic change | No |
| 271, 272 (n = 2) | Autologous | 12, 41 | Spongiotic dermatitis | No |
| 358 | Autologous | 1 | Pityrosporumfolliculitis | No |
| 55 | 6/6 | 101 | Phototoxic eruption | No |
| 79 | 6/6 | 18 | Morbilliform eruption | No |
| 85 | 6/6 | 41 | Spongiotic dermatitis | No |
| 103 | 6/6 | 31 | Morbilliform eruption | No |
| 119 | 6/6 | 33 | Morbilliform eruption | No |
| 132 | 6/6 | 21 | Interface dermatitis (EM/drug eruption) | No |
| 303, 352 (n = 2) | Autologous | 5, 21 | Morbilliform eruption | Yes |
| 92 | 6/6 | 73 | Grade II GVHD | Yes |
| 99 | 6/6 | 34 | Grade II GVHD | Yes |
| 116 | 6/6 | 34 | Grade II GVHD | Yes |
| 121 | 6/6 | 26 | Grade II GVHD | Yes |
| 137 | 6/6 | 21 | Grade II GVHD | Yes |
| 139 | 5/6 | 13 | Grade I GVHD | Yes |
| 81 | 5/6 | 25 | Grade II GVHD | Yes |
Patients undergoing one biopsy only. With the exception of UPIN 132, no patients were receiving steroid therapy at the time of skin biopsy.